IN BRIEF: RTW Venture Fund Sees Expenses Increase; Looks Towards China

RTW Venture Fund Ltd - New York-based investment company which invests in life sciences, ...

Alliance News 24 September, 2020 | 2:37PM
Email Form

RTW Venture Fund Ltd - New York-based investment company which invests in life sciences, biopharmaceutical, and medical technology companies - Net asset value per share at June 30 of USD1.34, up from USD1.27 at December 31, 2019. Loss for the first half ended June 30 widens to USD2.2 million from USD29,725 million a year prior. Management fees were biggest expense at USD1.2 million, up from nothing the year before. Believes there is a significant demand for reliable capital providers, such as itself, to continue to support scientific innovation and development of transformative therapies for patients. Intends to grow the company's portfolio, keeping to a 80%-20% split, where 80% is invested in biopharmaceutical assets and 20% across medical technology assets. To further explore opportunities in China.

Current stock price: USD1.54

Year-to-date change: up 12%

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
RTW Venture Ord 1.60 USD 0.00 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies